Showing results (51-60 of 557) with videos related to
Sort By:
Pageof 56
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Locally advanced rectal cancer: time for precision therapeuticsMartin R Weiser, Zhen Zhang, Deborah SchragJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Nodal staging score: a tool to assess adequate staging of node-negative colon cancerMithat Gönen, Deborah Schrag, Martin R WeiserJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practiceHoward I Scher, Michael J Morris, Ethan Basch, et al.Journal of Herbal Pharmacotherapy|July 27, 2004
Thyme (Thymus vulgaris L.), thymolEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.JCO Clinical Cancer Informatics|March 1, 2023
Tenets for Implementing Electronic Patient-Reported Outcomes for Remote Symptom Monitoring During Cancer TreatmentEthan Basch, Gabrielle Rocque, Gita Mody, et al.Alternative Medicine Review : a Journal of Clinical Therapeutic|March 4, 2003
Therapeutic applications of fenugreekEthan Basch, Catherine Ulbricht, Grace Kuo, et al.The American Journal of Managed Care|December 11, 2025
Expert consensus on essential characteristics of oncology value-based paymentMichael Fazio, Rhonda Henschel, Aaron J Lyss, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 21, 2024
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)Gina L Mazza, Amylou C Dueck, Brenda Ginos, et al.JAMA|June 2, 2023
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical TrialDeborah Schrag, Hajime Uno, Rachel Rosovsky, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2022
CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness AnalysisFernando Alarid-Escudero, Deborah Schrag, Karen M KuntzPageof 56